It takes more than having a good idea to find a drug, so the more time a drug discoverer can save in comprehensively identifying all the relevant information, evidence and data, the better.
Carl Robinsons discusses some of the key issues data science teams encounter when building their own datasets, and how a vendor like CCC can help eliminate these issues.
Utilizing deep search can help an organization reduce the manual effort needed to secure crucial data found in gaps, such as across multiple unconnected data sources.
CCC’s Roy Kaufman writes in The Scholarly Kitchen about how generative AI has changed the dynamic of the EU’s Digital Single Market Copyright Directive (DSM), creating risks and challenges for rightsholders and users alike.
CCC has been named to the KMWorld 100 Companies That Matter in Knowledge Management 2023, a list of organizations with pioneering solutions and notable modifications to existing products with a focus on innovation, agility, and the customer.
The days when a pharma company could base its future on discovering a few new drugs are gone, so to grow a pipeline of new drugs, companies explore new therapy areas and technologies.
CCC has continuously developed its RightFind XML offering since its inception in 2016, and we now offer even more flexible ways to incorporate scientific articles from more than 50 publishers into AI and machine-learning initiatives.
CCC joins with partners Causaly and Scite for an exclusive panel interview that will feature real-world ways these emerging technologies can benefit information professionals across the healthcare and pharmaceutical industries.
When consuming full-text content, there are many factors a knowledge manager should consider when trying to develop an optimal workflow that is suitable for their organization’s needs. Here are a few.